COX-2 is a novel target in therapy of mycosis fungoides

K. L.M. Kopp, S. Dabelsteen, T. Krejsgaard, K. W. Eriksen, C. Geisler, J. C. Becker, M. Wasik, N. Odum, A. Woetmann

Research output: Contribution to journalLetterpeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)2127-2129
Number of pages3
JournalLeukemia
Volume24
Issue number12
DOIs
StatePublished - Dec 2010

Keywords

  • Animals
  • Celecoxib
  • Cell Line, Tumor
  • Cyclooxygenase 2 Inhibitors/therapeutic use
  • Humans
  • Ki-67 Antigen/analysis
  • Mice
  • Mycosis Fungoides/drug therapy
  • Pyrazoles/therapeutic use
  • Skin Neoplasms/drug therapy
  • Sulfonamides/therapeutic use
  • Xenograft Model Antitumor Assays

Fingerprint

Dive into the research topics of 'COX-2 is a novel target in therapy of mycosis fungoides'. Together they form a unique fingerprint.

Cite this